Actionable news
All posts from Actionable news
Actionable news in RTRX: RETROPHIN Inc,

Retrophin's kidney drug succeeds in mid-stage study

Retrophin Inc said its rare kidney disorder drug met the main goal of a mid-stage study.

The drug, sparsentan, was tested in patients with focal segmental glomerulosclerosis (FSGS), which is...